As brain health becomes an ever greater concern for people of all ages, the nation’s largest senior living provider is now guiding its residents on developing and putting into practice personalized brain health plans. Brookdale devised the new resident program with the help of a neuropsychologist specializing in brain health. The company is putting it into place at its independent and assisted living communities across the country.
Through the new initiative, Brookdale’s residents will be offered a four-session course that explains key factors in brain health through classroom learning and hands-on activities. Each participant will be guided on creating an individual brain health plan to use on a daily basis. The course was developed with the assistance of Dr. Paul Nussbaum, who is Board Certified in clinical and geropsychology with a specialty in neuropsychology. An adjunct professor of neurological surgery at the University of Pittsburgh, he is the author of “Save Your Brain.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7722157-brookdale-brain-health/
Seqirus announced today that the National Adult and Influenza Immunization Summit (NAIIS) awarded the organization with the 2016 Immunization Excellence Award for best Corporate Campaign. The accolade recognizes Seqirus’ creative and collaborative efforts to improve vaccination awareness and rates during the 2015-16 influenza season. The award was presented yesterday during the NAIIS Summit in Atlanta, Georgia.
“We are pleased to receive this prestigious honor, and thankful to our partners, Families Fighting Flu and several collegiate student organizations, for their dedication to spreading the word about the dangers of flu and encouraging their peers to get vaccinated,” said Dr. Marie Mazur, Vice President of Global Commercial Development and Policy. “Moving forward, Seqirus is committed to building on this season’s success with college students and continuing the important work of flu prevention for all.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7833751-seqirus-national-award-knockoutflu/
The U.S. Food and Drug Administration (FDA) is alerting pregnant women about the risks of listeriosis, a foodborne disease that can severely affect a pregnant women and her unborn child.
Listeria can affect all races and ethnic groups, but pregnant women are 10 times more likely than other healthy adults to get listeriosis due to hormonal changes that affect the immune system during pregnancy. Pregnant Hispanic women are about 24 times more likely than the general population to get listeriosis. A pregnant mother may pass Listeria onto her unborn baby without even knowing it because she doesn’t feel sick at all, yet the disease can lead to miscarriage, stillbirth, premature labor, the delivery of a low birthweight infant, a wide range of health problems for a newborn, or even infant death.
To view the multimedia release go to:
https://www.multivu.com/players/English/7953451-fda-listeriosis-prevention-pregnant-women/
DePuy Synthes Companies today announced the launch of Hit Play, an educational initiative that encourages those dealing with hip or knee pain to stop settling for a life on ‘pause’ and instead take action to get back to the activities and people they love most.
Osteoarthritis is one of the most common reasons for severe hip or knee pain, affecting nearly 27 million Americans today and will potentially affect up to 67 million people by 2030.1,2 In turn, demand for hip and knee replacements are expected to dramatically increase, yet many women see joint replacement as a “last resort” and often wait until the pain has become unbearable before turning to surgery. Through a series of compelling and relatable content, DePuy Synthes seeks to inspire the millions of people stuck on ‘pause’ due to hip or knee pain to explore joint replacement with a doctor, as a potential viable solution when they Hit Play.
To view the multimedia release go to:
http://www.multivu.com/players/English/79644241-lysol-madison-square-bgca-expose-germs/
Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Combining their expertise in clinical trials support and cellular therapies, BloodCenter of Wisconsin (BCW) and the San Diego Blood Bank (SDBB) have created a strategic partnership to accelerate advancements in research and patient care. Together, BloodCenter of Wisconsin and San Diego Blood Bank will offer Celluvative™ – a portfolio of products and clinical trial services that will include esoteric laboratory testing, blood products for research and manufacturing applications, cell processing, and access to a broad database of diverse donors who have expressed interest in clinical trials.
“Through the strength of our partnership, we are able to offer end-to-end services to academic organizations, research institutions and other industry partners who are working to develop novel cellular therapy approaches,” said Matthew Anderson, M.D., Ph.D., medical director, BloodCenter of Wisconsin Diagnostic Laboratories. “Among other offerings, our Celluvative portfolio enables access to an extremely diverse donor database – an invaluable resource to enable advances in the area of regenerative medicine and drug discovery.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7855451-bloodcenter-sdbb-celluvative/
A recent study found that only 47% of Americans are currently taking steps to prevent bone loss1, despite considering it to be of high importance. In an effort to educate the public about the importance of bone health, Sunsweet Growers has partnered with the International Osteoporosis Foundation (IOF) to support their annual World Osteoporosis Day (WOD) campaign. WOD is globally celebrated on October 20 and serves to create awareness for bone health and the steps that can be taken to protect bones including incorporating bone-building habits – like eating prunes – into a regular lifestyle routine.
Bones need the right nutrients to stay strong and healthy and research suggests that eating just 5-6 prunes (the Feel Good Fruit!) each day may help to prevent bone loss. However, many do not think about bone health until after a fracture or break occurs.
To view the multimedia release go to:
https://www.multivu.com/players/English/8410051-sunsweet-iof-world-osteoporosis-day-bone-health/
One to six in 1,000 children in the United States are born with severe to profound hearing loss.1 For a parent, that diagnosis can be life altering, and they are in need of help, information and support. Today, Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces IWantYouToHear.com as part of its ongoing commitment to parents seeking treatment options for their child’s severe to profound hearing loss.
For many parents with a child who has received a hearing loss diagnosis, the wish for their child is immediate and clear: “I want you to hear.” They want their child to hear the birds and their favorite songs, learn to develop speech and language, and most of all, they want their child to hear them say “I love you.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7658351-cochlear-americas-i-want-you-to-hear/
Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
Do You Want Your Love Life Back?
Have you lost your love making ability? Has your hardness changed and has caused you some embarrassment? You don’t have to suffer the shame or fear that comes with lack of hardness when your love partner is ready for you. Are you starting for feel like less of a man?
Capatriti Olive Oil teams up with celebrity chef and owner of “Streets” restaurant in Brooklyn, NY, Roblé Ali, to create viral videos featuring delicious spring and summer themed dishes to benefit celebrity-backed NYC charity organization, God’s Love We Deliver. Consumers can join in on the effort to donate funds toward the amazingly honest and sincere mission of God’s Love We Deliver to help those with severe and chronic illnesses through nutritious meals. Share Capatriti’s Honest Olive Oil campaign videos featuring Chef Roblé on Facebook, Instagram or Twitter and tag @CapatritiOliveOil and #HonestOliveOil. For every share, repost or retweet on social media, Capatriti will donate $1 to God's Love We Deliver, up to $5,000.
To view the multimedia release go to:
https://www.multivu.com/players/English/8077251-capatriti-gourmet-factory-honest-olive-oil-campaign/
